{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:34:09Z","timestamp":1760060049276,"version":"build-2065373602"},"reference-count":19,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.clindermatol.2020.06.006","type":"journal-article","created":{"date-parts":[[2020,6,19]],"date-time":"2020-06-19T04:42:28Z","timestamp":1592541748000},"page":"750-756","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Systemic steroids and risk of fecal-oral shedding and increased transmission of SARS-CoV-2 in pemphigus cases"],"prefix":"10.1016","volume":"38","author":[{"given":"Manoj","family":"Pawar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehak","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clindermatol.2020.06.006_bb0005","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s40257-020-00514-2","article-title":"Managing cutaneous immune-mediated diseases during the COVID-19 pandemic","volume":"21","author":"Torres","year":"2020","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.006_bb0010","doi-asserted-by":"crossref","first-page":"e235","DOI":"10.1016\/j.jaad.2020.04.005","article-title":"Treatment considerations for patients with pemphigus during the COVID-19 pandemic","volume":"82","author":"Shakshouk","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.006_bb0015","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/path.1570","article-title":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis","volume":"203","author":"Hamming","year":"2004","journal-title":"J Pathol"},{"key":"10.1016\/j.clindermatol.2020.06.006_bb0020","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1136\/gutjnl-2020-321195","article-title":"COVID-19 and the gastrointestinal tract: more than meets the eye","volume":"69","author":"Ng","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.clindermatol.2020.06.006_bb0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/JVI.02015-19","article-title":"Molecular mechanism for antibody-dependent enhancement of coronavirus entry","volume":"94","author":"Wan","year":"2020","journal-title":"J Virol"},{"key":"10.1016\/j.clindermatol.2020.06.006_bb0030","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1177\/019262338801600214","article-title":"The effects of steroids upon the gastrointestinal tract","volume":"16","author":"Black","year":"1988","journal-title":"Toxicol Pathol"},{"key":"10.1016\/j.clindermatol.2020.06.006_bb0035","doi-asserted-by":"crossref","first-page":"421","DOI":"10.4103\/0378-6323.29337","article-title":"Study of upper gastrointestinal tract involvement in pemphigus by esophago-gastro-duodenoscopy","volume":"72","author":"Rao","year":"2006","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.clindermatol.2020.06.006_bb0040","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/S0140-6736(20)30691-7","article-title":"Immunosuppression for hyperinflammation in COVID-19: a double-edged sword?","volume":"395","author":"Ritchie","year":"2020","journal-title":"Lancet"},{"author":"World Health Association","key":"10.1016\/j.clindermatol.2020.06.006_bb0045"},{"key":"10.1016\/j.clindermatol.2020.06.006_bb0050","doi-asserted-by":"crossref","unstructured":"Brenner EJ, Ungaro RC, Gearry RB, et al: Corticosteroids, but not TNF antagonists, are associated with adverse COVID-19 outcomes in patients with inflammatory bowel diseases: results from an international registry [e-pub ahead of print]. Gastroenterology. doi: https:\/\/doi.org\/10.1053\/j.gastro.2020.05.032, accessed 06\/11\/2020.","DOI":"10.1053\/j.gastro.2020.05.032"},{"issue":"3","key":"10.1016\/j.clindermatol.2020.06.006_bb0055","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/jdv.12772","article-title":"Pemphigus. S2 Guideline for diagnosis and treatment \u2013 guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV)","volume":"29","author":"Hertl","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"10.1016\/j.clindermatol.2020.06.006_bb0060","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1111\/bjd.15930","article-title":"British Association of Dermatologists\u2019 guidelines for the management of pemphigus vulgaris 2017","volume":"177","author":"Harman","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.006_bb0065","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.3389\/fimmu.2019.01418","article-title":"Pemphigus: current and future therapeutic strategies","volume":"10","author":"Maglie","year":"2019","journal-title":"Front Immunol"},{"author":"Bad.org.uk","key":"10.1016\/j.clindermatol.2020.06.006_bb0070"},{"issue":"4","key":"10.1016\/j.clindermatol.2020.06.006_bb0075","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1590\/abd1806-4841.20176481","article-title":"Biologic therapy-induced pemphigus","volume":"92","author":"Hayashida","year":"2017","journal-title":"An Bras Dermatol"},{"author":"England.nhs.uk","key":"10.1016\/j.clindermatol.2020.06.006_bb0080"},{"key":"10.1016\/j.clindermatol.2020.06.006_bb0085","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciaa601","article-title":"COVID-19 Management Task Force, Early Short Course Corticosteroids in Hospitalized Patients with COVID-19","author":"Fadel","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clindermatol.2020.06.006_bb0090","article-title":"Hydroxychloroquine or chloroquine for treatment or prophylaxis of COVID-19: a living systematic review","author":"Hernandez","year":"2020","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clindermatol.2020.06.006_bb0095","article-title":"Plasmapheresis treatment in COVID-19-related autoimmune meningoencephalitis: Case series [published online ahead of print, 2020 May 7]","author":"Dogan","year":"2020","journal-title":"Brain Behav Immun."}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X20301371?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X20301371?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:18:44Z","timestamp":1760033924000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X20301371"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S0738081X20301371"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2020.06.006","relation":{},"ISSN":["0738-081X"],"issn-type":[{"type":"print","value":"0738-081X"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systemic steroids and risk of fecal-oral shedding and increased transmission of SARS-CoV-2 in pemphigus cases","name":"articletitle","label":"Article Title"},{"value":"Clinics in Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clindermatol.2020.06.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}